Until the last few years, UK life sciences has been a sector that only a handful of big investors have dabbled in, and with the epicentre of activity taking place in the golden triangle latterly known as the Oxford-Cambridge Arc.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies